References
1. I. Heyman, E. Fombonne, H. Simmons, T. Ford, H. Meltzer, R. Goodman (2003) Prevalence of obsessive-compulsive disorder in the British nationwide survey of child mental health. Int Rev Psychiatry 15:178–184.
2. G. Masi, S. Millepiedi, G. Perugi, C. Pfanner, S. Berloffa, C. Pari, M. Mucci, H.S. Akiskal (2010) A naturalistic exploratory study of the impact of demographic, phenotypic and comorbid features in pediatric obsessive-compulsive disorder. Psychopathology 43:69–78.
3. H. Kandemir, M. Abuhandan, N. Aksoy, E. Savik, C. Kaya (2013) Oxidative imbalance in child and adolescent patients with obsessive compulsive disorder. J Psychiatr Res 47:1831–1834.
4. N. Konuk, I.O. Tekın, U. Ozturk, L. Atik, N. Atasoy, S. Bektas, A. Erdogan (2007) Plasma Levels of Tumor Necrosis Factor-Alpha and Interleukin-6 in Obsessive Compulsive Disorder. Mediators Inflamm 2007:1–5.
5. A. Berdowska, K. Zwirska-Korczala (2001) Neopterin measurement in clinical diagnosis. J Clin Pharm Ther 26:319–329.
6. N. Müller (2014) Immunology of major depression. Neuroimmunomodulation 21:123–130.
7. B. Sperner-Unterweger, C. Kohl, D. Fuchs (2014) Immune changes and neurotransmitters: Possible interactions in depression?. Prog Neuro-Psychopharmacology Biol Psychiatry 48:268–276.
8. B. Strasser, B. Sperner-Unterweger, D. Fuchs, J.M. Gostner (2016) Mechanisms of Inflammation-Associated Depression: Immune Influences on Tryptophan and Phenylalanine Metabolisms, in: R. Dantzer, L. Capuron (Eds.), Inflammation-Associated Depress. Evidence, Mech. Implic. Springer International Publishing, Cham pp. 95–115.
9. O. Akyol, S. Zoroglu, F. Armutcu, S. Sahin, A. Gurel (2004) Nitric oxide as a physiopathological factor in neuropsychiatric disorders. In Vivo (Brooklyn) 18:377–390.
10. M. Yanik, H. Vural, A. Kocyiǧit, H. Tutkun, S.S. Zoroǧlu, H. Herken, H.A. Savaş, A. Köylü, Ö. Akyol (2003) Is the arginine-nitric oxide pathway involved in the pathogenesis of schizophrenia?. Neuropsychobiology 47:61–65.
11. H. Bielau, R. Brisch, J. Bernard-Mittelstaedt, H. Dobrowolny, T. Gos, B. Baumann, C. Mawrin, H.G. Bernstein, B. Bogerts, J. Steiner (2012) Immunohistochemical evidence for impaired nitric oxide signaling of the locus coeruleus in bipolar disorder. Brain Res 1459:91–99.
12. E. O’Toole, M. V. Doucet, E. Sherwin, A. Harkin (2016) Novel Targets in the Glutamate and Nitric Oxide Neurotransmitter Systems for the Treatment of Depression. Elsevier Inc.
13. F. Ünal, F. Öktem, F. Çetin Çuhadaroğlu, S.E. Çengel Kültür, D. Akdemir, D. Foto Özdemir, H.T. Çak, D. Ünal, K. Tiraş, C. Aslan, B.M. Kalayci, B.S. Aydos, F. Kütük, E. Taşyürek, R. Karaokur, B. Karabucak, B. Karakök, Y. Karaer, A. Artik (2019) Reliability and validity of the schedule for affective disorders and schizophrenia for school-age children-present and lifetime version, DSM-5 November 2016-Turkish adaptation (K-SADS-PL-DSM-5-T). Turk Psikiyatr Derg 30:42–50.
14. A.G. Yucelen, A. Rodopman-Arman, V. Topcuoglu, M.Y. Yazgan, G. Fisek (2006) Interrater reliability and clinical efficacy of Children’s Yale-Brown Obsessive-Compulsive Scale in an outpatient setting. Compr Psychiatry 47:48–53.
15. S.E. Swedo, H.L. Leonard, M. Garvey, B. Mittleman, A.J. Allen, S. Perlmutter, S. Dow, J. Zamkoff, B.K. Dubbert, L. Lougee (1998) Pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections: Clinical description of the first 50 cases. Am J Psychiatry 155:264–271.
16. S.B.A.H.A. Fluitman, D.A.J.P. Denys, C.J. Heijnen, H.G.M. Westenberg (2010) Disgust affects TNF-α, IL-6 and noradrenalin levels in patients with obsessive-compulsive disorder. Psychoneuroendocrinology 35:906–911.
17. R. Çolak Sivri, A. Bilgiç, İ. Kılınç (2018) Cytokine, chemokine and BDNF levels in medication-free pediatric patients with obsessive–compulsive disorder. Eur Child Adolesc Psychiatry 27:977–984.
18. L. Erbay, N. Kavuran, Ç. Taşkapan, L. İnce, S. Yoloğlu, H. Temelli, S. Nal (2018) Serum IL-1, IL-2, IL-4, IL-6, IL-10, TNF-α, and IFN-γ levels in drug-free, comorbidity-free obsessive-compulsive disorder patients. Anatol J Psychiatry 19:157–162.
19. T.D. Cosco, T. Pillinger, H. Emam, M. Solmi, S. Budhdeo, A. Matthew Prina, M. Maes, D.J. Stein, B. Stubbs, A.F. Carvalho (2019) Immune Aberrations in Obsessive-Compulsive Disorder: a Systematic Review and Meta-analysis. Mol Neurobiol 56:4751–4759.
20. F. Brambilla, G. Perna, L. Bellodi, C. Arancio, A. Bertani, G. Perini, C. Carraro, F. Gava (1997) Plasma Interleukin-1β and Tumor Necrosis Factor Concentrations in Obsessive–Compulsive Disorders. Biol Psychiatry 42:976–981.
21. P. Monteleone, F. Catapano, M. Fabrazzo, A. Tortorella, M. Maj (1998) Decreased blood levels of tumor necrosis factor-alpha in patients with obsessive-compulsive disorder. Neuropsychobiology 37:182–185.
22. D. Lilic, A.J. Cant, M. Abinun, J.E. Calvert, G.P. Spickett (1997) Cytokine production differs in children and adults. Pediatr Res 42:237–240.
23. M. Kuloğlu, M. Atmaca, S. Önal, Ö. Geçici, V. Bulut, E. Tezcan (2007) Neopterin levels and dexamethasone suppression test in obsessive–compulsive disorder. Psychiatry Res 151:265–270.
24. T.L. Sweeten, D.J. Posey, C.J. McDougle (2003) High blood monocyte counts and neopterin levels in children with autistic disorder. Am J Psychiatry 160:1691–1693.
25. R. Hoekstra, D. Fekkes, L. Pepplinkhuizen, A.J.M. Loonen, S. Tuinier, W.M.A. Verhoeven (2006) Nitric oxide and neopterin in bipolar affective disorder. Neuropsychobiology 54:75–81.
26. M.A. Richardson, L.L. Read, C.L.T. Clelland, M.A. Reilly, H.M. Chao, R.W. Guynn, R.F. Suckow, J.D. Clelland (2005) Evidence for a tetrahydrobiopterin deficit in schizophrenia. Neuropsychobiology 52:190–201.
27. B. Widner, A. Laich, B. Sperner-Unterweger, M. Ledochowski, D. Fuchs (2002) Neopterin production, tryptophan degradation, and mental depression—what is the link?. Brain Behav Immun 16:590–595.
28 M. Atmaca, E. Tezcan, M. Kuloglu, B. Ustundag (2005) Plasma nitrate values in patients with obsessive‐compulsive disorder. Psychiatry Clin Neurosci 59:621–623.
29 M. Topaloglu, E. Tuzun, H. Gulec, E.S. Bireller, B. Cakmakoglu, C.I. Kucukali (2017) Neuronal nitric oxide synthase polymorphisms in obsessive-compulsive disorder. Nord J Psychiatry 71:115–119.
30. A. Maia, J. Oliveira, M. Lajnef, L. Mallet, R. Tamouza, M. Leboyer, A.J. Oliveira‐Maia (2019) Oxidative and nitrosative stress markers in obsessive–compulsive disorder: a systematic review and meta‐analysis. Acta Psychiatr Scand 139:420–433.